Asymmetry Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-155,232
| Closed | -$8.56M | – | 44 |
|
|
2020
Q3 | $8.56M | Sell |
155,232
-16,084
| -9% | -$887K | 5.5% | 4 |
|
|
2020
Q2 | $10.8M | Buy |
171,316
+84,739
| +98% | +$5.35M | 8.29% | 3 |
|
|
2020
Q1 | $4.42M | Buy |
+86,577
| New | +$4.42M | 4.84% | 8 |
|
|
2019
Q4 | – | Sell |
-75,011
| Closed | -$3.64M | – | 41 |
|
|
2019
Q3 | $3.64M | Sell |
75,011
-239,206
| -76% | -$11.6M | 7.8% | 4 |
|
|
2019
Q2 | $16.5M | Buy |
314,217
+228,556
| +267% | +$12M | 8.95% | 2 |
|
|
2019
Q1 | $4.53M | Sell |
85,661
-21,023
| -20% | -$1.11M | 7.58% | 5 |
|
|
2018
Q4 | $4.38M | Buy |
106,684
+3,235
| +3% | +$133K | 12.1% | 2 |
|
|
2018
Q3 | $3.93M | Buy |
103,449
+54,094
| +110% | +$2.06M | 3.63% | 9 |
|
|
2018
Q2 | $2.23M | Buy |
49,355
+27,355
| +124% | +$1.24M | 2.19% | 18 |
|
|
2018
Q1 | $1.06M | Buy |
+22,000
| New | +$1.06M | 1.33% | 27 |
|